These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 10856062)

  • 1. Cost effectiveness analysis of screening for sight threatening diabetic eye disease.
    James M; Turner DA; Broadbent DM; Vora J; Harding SP
    BMJ; 2000 Jun; 320(7250):1627-31. PubMed ID: 10856062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of optometry vs digital photography screening for diabetic retinopathy in a single district.
    Tu KL; Palimar P; Sen S; Mathew P; Khaleeli A
    Eye (Lond); 2004 Jan; 18(1):3-8. PubMed ID: 14707956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT.
    Broadbent DM; Wang A; Cheyne CP; James M; Lathe J; Stratton IM; Roberts J; Moitt T; Vora JP; Gabbay M; García-Fiñana M; Harding SP;
    Diabetologia; 2021 Jan; 64(1):56-69. PubMed ID: 33146763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of accuracy and cost effectiveness of clinical criteria and BUA for referral for BMD assessment by DXA in osteoporotic and osteopenic perimenopausal subjects.
    Langton CM; Langton DK; Beardsworth SA
    Technol Health Care; 1999; 7(5):319-30. PubMed ID: 10543417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incremental cost-effectiveness of screening and laser treatment for diabetic retinopathy and macular edema in Malawi.
    Vetrini D; Kiire CA; Burgess PI; Harding SP; Kayange PC; Kalua K; Msukwa G; Beare NAV; Madan J
    PLoS One; 2018; 13(1):e0190742. PubMed ID: 29300755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A relative cost-effectiveness analysis of different methods of screening for diabetic retinopathy.
    Sculpher MJ; Buxton MJ; Ferguson BA; Humphreys JE; Altman JF; Spiegelhalter DJ; Kirby AJ; Jacob JS; Bacon H; Dudbridge SB
    Diabet Med; 1991; 8(7):644-50. PubMed ID: 1833116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic retinopathy screening: a systematic review of the economic evidence.
    Jones S; Edwards RT
    Diabet Med; 2010 Mar; 27(3):249-56. PubMed ID: 20536486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool Diabetic Eye Study.
    Harding SP; Broadbent DM; Neoh C; White MC; Vora J
    BMJ; 1995 Oct; 311(7013):1131-5. PubMed ID: 7580708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shoulder acute pain in primary health care: is retraining GPs effective? The SAPPHIRE randomized trial: a cost-effectiveness analysis.
    McKenna C; Bojke L; Manca A; Adebajo A; Dickson J; Helliwell P; Morton V; Russell I; Torgerson D; Watson J
    Rheumatology (Oxford); 2009 May; 48(5):558-63. PubMed ID: 19258378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambulatory photographic screening for diabetic retinopathy in nursing homes.
    Anderson S; Broadbent DM; Swain JY; Vora JP; Harding SP
    Eye (Lond); 2003 Aug; 17(6):711-6. PubMed ID: 12928682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The implementation of prompted retinal screening for diabetic eye disease by accredited optometrists in an inner-city district of North London: a quality of care study.
    Burnett S; Hurwitz B; Davey C; Ray J; Chaturvedi N; Salzmann J; Yudkin JS
    Diabet Med; 1998 Nov; 15 Suppl 3():S38-43. PubMed ID: 9829768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of Screening for Intermediate Age-Related Macular Degeneration during Diabetic Retinopathy Screening.
    Chan CK; Gangwani RA; McGhee SM; Lian J; Wong DS
    Ophthalmology; 2015 Nov; 122(11):2278-85. PubMed ID: 26315045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity and specificity of digital retinal imaging for screening diabetic retinopathy.
    Lopez-Bastida J; Cabrera-Lopez F; Serrano-Aguilar P
    Diabet Med; 2007 Apr; 24(4):403-7. PubMed ID: 17298591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of sight in diabetes: developing a national risk reduction programme.
    Garvican L; Clowes J; Gillow T
    Diabet Med; 2000 Sep; 17(9):627-34. PubMed ID: 11051281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of screening policies for diabetic retinopathy using simulation.
    Davies R; Roderick P; Canning C; Brailsford S
    Diabet Med; 2002 Sep; 19(9):762-70. PubMed ID: 12207814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
    Nguyen HV; Tan GS; Tapp RJ; Mital S; Ting DS; Wong HT; Tan CS; Laude A; Tai ES; Tan NC; Finkelstein EA; Wong TY; Lamoureux EL
    Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-utility of telemedicine to screen for diabetic retinopathy in India.
    Rachapelle S; Legood R; Alavi Y; Lindfield R; Sharma T; Kuper H; Polack S
    Ophthalmology; 2013 Mar; 120(3):566-573. PubMed ID: 23211635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of implementing automated grading within the national screening programme for diabetic retinopathy in Scotland.
    Scotland GS; McNamee P; Philip S; Fleming AD; Goatman KA; Prescott GJ; Fonseca S; Sharp PF; Olson JA
    Br J Ophthalmol; 2007 Nov; 91(11):1518-23. PubMed ID: 17585001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the cost-effectiveness of three approaches to screening for and treating sight-threatening diabetic retinopathy.
    Porta M; Rizzitiello A; Tomalino M; Trento M; Passera P; Minonne A; Pomero F; Gamba S; Castellazzi R; Montanaro M; Sivieri R; Orsi R; Bondonio P; Molinatti GM
    Diabetes Metab; 1999 Mar; 25(1):44-53. PubMed ID: 10335423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an economic model to assess the cost effectiveness of asthma management strategies.
    Price MJ; Briggs AH
    Pharmacoeconomics; 2002; 20(3):183-94. PubMed ID: 11929348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.